Clinical Features	Time to Death	AGE	GENDER	KARNOFSKY.PERFORMANCE.SCORE	HISTOLOGICAL.TYPE	PATHOLOGY.T	PATHOLOGY.N	PATHOLOGICSPREAD(M)	TUMOR.STAGE	RADIATIONS.RADIATION.REGIMENINDICATION	NEOADJUVANT.THERAPY
Statistical Tests	logrank test	ANOVA	Fisher's exact test	ANOVA	Chi-square test	Chi-square test	Chi-square test	Chi-square test	Chi-square test	Fisher's exact test	Fisher's exact test
mRNA CNMF subtypes	0.337	0.477	0.272		0.3	0.489	0.572	0.504	0.147	1	0.921
mRNA cHierClus subtypes	0.671	0.557	0.383		0.274	0.479	0.651	1	0.274	1	1
CN CNMF	0.663	0.000101	0.34	0.376	0.326	0.674	0.771	0.717	0.321	0.449	0.956
METHLYATION CNMF	0.0209	0.287	0.024	0.679	0.274	0.84	0.4	0.258	0.695	0.0788	0.359
RPPA CNMF subtypes	0.0207	0.0204	0.211	0.0806	0.187	0.165	0.54	0.913	0.908	1	0.175
RPPA cHierClus subtypes	0.0117	0.00368	0.222	0.295	0.00941	0.67	0.51	0.683	0.982	0.415	0.633
RNAseq CNMF subtypes	0.00636	0.0927	0.000904	0.718	0.128	0.588	0.0827	0.956	0.0789	1	0.428
RNAseq cHierClus subtypes	2.54e-05	0.124	0.00868	0.644	0.143	0.422	0.00983	0.496	0.0218	1	0.509
MIRseq CNMF subtypes	0.0975	0.206	0.809	0.919	0.206	0.578	0.721	0.11	0.889	0.858	0.194
MIRseq cHierClus subtypes	0.071	0.11	0.000771	0.59	0.137	0.841	0.342	0.756	0.246	0.74	0.0393
